Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Integrating high-content screening and ligand-target prediction to identify mechanism of action.

Integrating high-content screening and ligand-target prediction to identify mechanism of action. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Integrating high-content screening and ligand-target prediction to identify mechanism of action. Abstract Text:

    daniel w youngDaniel W Young,andreas benderAndreas Bender,jonathan hoytJonathan Hoyt,elizabeth mcwhinnieElizabeth McWhinnie,gung-wei chirnGung-Wei Chirn,charles y taoCharles Y Tao,john a tallaricoJohn A Tallarico,mark labowMark Labow,jeremy l jenkinsJeremy L Jenkins,timothy j mitchisonTimothy J Mitchison,yan fengYan Feng,daniel w youngDaniel W Young,andreas benderAndreas Bender,jonathan hoytJonathan Hoyt,elizabeth mcwhinnieElizabeth McWhinnie,gung-wei chirnGung-Wei Chirn,charles y taoCharles Y Tao,john a tallaricoJohn A Tallarico,mark labowMark Labow,jeremy l jenkinsJeremy L Jenkins,timothy j mitchisonTimothy J Mitchison,yan fengYan Feng,

    High-content screening is transforming drug discovery by enabling simultaneous measurement of multiple features of cellular phenotype that are relevant to therapeutic and toxic activities of compounds. High-content screening studies typically generate immense datasets of image-based phenotypic information, and how best to mine relevant phenotypic data is an unsolved challenge. Here, we introduce factor analysis as a data-driven tool for defining cell phenotypes and profiling compound activities. This method allows a large data reduction while retaining relevant information, and the data-derived factors used to quantify phenotype have discernable biological meaning. We used factor analysis of cells stained with fluorescent markers of cell cycle state to profile a compound library and cluster the hits into seven phenotypic categories. We then compared phenotypic profiles, chemical similarity and predicted protein binding activities of active compounds. By integrating these different descriptors of measured and potential biological activity, we can effectively draw mechanism-of-action inferences.

    Integrating high-content screening and ligand-target prediction to identify mechanism of action. Publishing Authors By Initials

    dw youngDW Young,a benderA Bender,j hoytJ Hoyt,e mcwhinnieE McWhinnie,gw chirnGW Chirn,cy taoCY Tao,ja tallaricoJA Tallarico,m labowM Labow,jl jenkinsJL Jenkins,tj mitchisonTJ Mitchison,y fengY Feng,dw youngDW Young,a benderA Bender,j hoytJ Hoyt,e mcwhinnieE McWhinnie,gw chirnGW Chirn,cy taoCY Tao,ja tallaricoJA Tallarico,m labowM Labow,jl jenkinsJL Jenkins,tj mitchisonTJ Mitchison,y fengY Feng,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Integrating high-content screening and ligand-target prediction to identify mechanism of action. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Nature chemical biology

    VOLUME: 4

    Page Numbers: 59-68

    Journal Abbreviation: Nat. Chem. Biol.

    ISSN: 1552-4469

    DAY: 9

    MONTH: 12

    YEAR: 2007

    Integrating high-content screening and ligand-target prediction to identify mechanism of action. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101231976

    Integrating high-content screening and ligand-target prediction to identify mechanism of action. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Integrating high-content screening and ligand-target prediction to identify mechanism of action. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Integrating high-content screening and ligand-target prediction to identify mechanism of action.

    AFFILIATION: Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA78048

    ACRONYM: CA

    MEDLINETA: Nat Chem Biol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Integrating high-content screening and ligand-target prediction to identify mechanism of action Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News